EGCG Green Tea Catechin Cardiovascular Meta-Analysis: LDL and Total Cholesterol Reduced
WELLNESS

EGCG Green Tea Catechin Cardiovascular Meta-Analysis: LDL and Total Cholesterol Reduced

By Olivia · · https://www.mdpi.com/journal/nutrients
KO | EN

A review aggregating green tea’s cardiovascular effects was published in 2025. EGCG (epigallocatechin gallate)-centered catechins meaningfully reduced LDL cholesterol and total cholesterol, and improved vascular endothelial function.

Meta-analysis core results

LDL cholesterol reduction: Green tea catechins consistently reduced. Meta-analyses show -7~10 mg/dL reduction.

Total cholesterol reduction: Consistent effect. -5~8 mg/dL reduction.

HDL cholesterol: Minimal effect.

Vascular endothelial function improvement: FMD (flow-mediated dilation) improvement.

Mild blood pressure reduction: Some data.

Oxidative stress reduction: Consistent antioxidant effect.

Dose: EGCG 270 mg/day or standard green tea extract 500~700 mg/day.

What are EGCG and catechins

Catechin: Polyphenol flavonoid. Abundant in green tea.

EGCG (epigallocatechin gallate): Most active among catechins. 50~80% of green tea polyphenols.

Other catechins: EGC, ECG, EC. EGCG strongest.

Green vs black tea: Green tea unoxidized - catechins preserved. Black tea oxidized - theaflavins/thearubigins.

Dietary sources: Green tea 1 cup (2.5 g) contains EGCG approximately 70~100 mg.

Supplements: Green tea extract 500~700 mg (EGCG standardized 50%).

Mechanism

LDL oxidation inhibition: LDL cholesterol oxidation initiates atherosclerosis. Catechins inhibit oxidation.

HMG-CoA reductase mild inhibition: Cholesterol synthesis weak inhibition.

Bile acid absorption mild reduction: Cholesterol excretion adjunct.

Vascular endothelial function: NO support. Vasodilation.

Antioxidant: Direct free radical scavenging + antioxidant enzyme activation.

Inflammation reduction: NF-κB inhibition, CRP reduction.

Fatty acid oxidation mild increase: Exercise matrix adjunct.

Who fits

Mild high LDL: After physician evaluation. Statin foundation.

Metabolic syndrome: Oxidative stress adjunct.

Pre-diabetes: Some data.

General antioxidant matrix: Diet sufficient.

Who should be careful

Liver injury risk: High-dose EGCG (700+ mg/day) hepatotoxicity reports. Avoid 800+ mg/day. Avoid empty stomach.

Iron absorption reduction: Green tea with meals reduces non-heme iron absorption. Iron-deficient anemia patients time-separate.

Drug interactions: Caution with warfarin (vitamin K), beta blockers, some chemotherapies. Consult physician.

Caffeine: Green tea 1 cup 30~50 mg caffeine. Caffeine sensitivity caution.

Pregnancy/breastfeeding: Dietary amounts safe. Supplements consult physician.

Dose and forms

Diet first: Green tea 3~5 cups/day.

Supplement: Green tea extract 500 mg/day (EGCG 250 mg).

Upper limit: EGCG <700 mg/day. Avoid empty stomach.

Timing: With meals or after meals.

Duration: Effect assessment at 8~12 weeks.

Form comparison

Green tea (leaves): Natural form. Caffeine + catechins. Best absorption.

Matcha: Leaf powder. Strong concentration.

Green tea extract supplement: Standardized EGCG 50%. Caffeine-removed option.

EGCG single: Supplement. Hepatotoxicity risk.

Decaffeinated green tea: Option for caffeine-sensitive.

Other cholesterol adjuncts

Omega-3: Triglycerides -20~30%.

Dietary fiber (beta-glucan): LDL -5~10%.

Phytosterols: LDL -8~12%.

Niacin (B3): HDL increase. Physician evaluation.

Red yeast rice: Monacolin K = natural statin. Physician evaluation.

Green tea + omega-3 + dietary fiber matrix synergy.

Daily guide

Step 1 - Physician evaluation: Cholesterol panel, risk factors.

Step 2 - Dietary foundation: Mediterranean diet, dietary fiber, exercise, weight management.

Step 3 - Green tea diet: 3~5 cups/day. With meals.

Step 4 - Supplement option: Green tea extract 500 mg/day. After physician evaluation.

Step 5 - 8~12 week assessment: Cholesterol panel tracking.

Step 6 - Monitoring: Liver enzymes (AST/ALT), drug interactions.

EGCG is a natural option in the cardiovascular matrix. Diet first. Supplements after physician evaluation.